New York, NY · Founded 2024 · Privately Held (backing)
Developer of a cell restoration technology designed to enable longevity. HeXembio is based in New York, NY and was founded in 2024. Its last reported valuation was $25 million in Mar 2025. It has raised $19.8 million.
Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$19.8M
Last round
—
Team — not yet on record
No current team members for HeXembio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HeXembio with a free account
·The complete investor list: 23 names
·Watch HeXembio: the Monday email on marks, rounds and moves
